24/09/2026NCIRS webinarCOVID-19 vaccination in 2026 – preparing for the transition to the National Immunisation Program NCIRS webinar series Main navigation Australian Immunisation Handbook Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources NCIRS webinar series 24/09/2026 – COVID-19 vaccination in 2026 – preparing for the transition to the National Immunisation Program 24/06/2026 – Pneumococcal vaccination for adults: expanding disease protection 23/04/2026 – RSV vaccines and prevention programs: evidence, safety and impact 05/03/2026 – Influenza vaccination in 2026: a new era of protection 05/11/2025 – Protecting adolescents through immunisation: insights, drivers and opportunities for action 25/09/2025 – What’s new in pneumococcal vaccination for infants, children and adolescents 25/06/2025 – Navigating vaccination for immunocompromised patients: New Handbook guidance 27/03/2025 – Triple protection: Vaccines for influenza, COVID-19 and RSV in 2025 06/02/2025 – Australian RSV immunisation update – new funded programs for infant protection 10/10/2024 – Falling childhood vaccination rates: current context and future strategies 08/08/2024 – Rabies, travel vaccines and global trends in vaccine-preventable diseases 27/03/2024 – Influenza and COVID-19 vaccination update 07/03/2024 – RSV vaccines for the protection of older adults 27/02/2024 – New RSV vaccine and antibody to prevent disease in infants 07/11/2023 - New shingles vaccine on Australia's NIP 22/09/23 – Vaccination for people with disability 05/05/2023: HPV in 2023 – latest vaccine recommendations and research 16/03/2023: COVID-19 and influenza vaccination update 2023 8/11/2022: Mpox (formerly monkeypox) vaccines 01/09/2022: Emerging vaccine preventable diseases and vaccination for travel 12/05/2022: Preventing shingles (herpes zoster) and its complications using zoster vaccines - and a quick update on COVID-19 vaccines 05/04/2022: Managing seasonal respiratory viruses: Flu and SARS-CoV-2 Winter 2022 03/03/2022: Living with COVID-19: Getting back to immunisation business as usual 8/12/2021: COVID-19 in children and adolescents: vaccines, transmission at school and disease outcomes 13/10/2021: Weighing up the benefits and risks of COVID-19 vaccination: a focus on safety - REGISTER NOW 26/08/21 - What’s next for Australia’s COVID-19 vaccine program? 24/06/2021 - Supporting COVID-19 vaccine access in the Indo-Pacific 30/04/2021: Australia’s COVID-19 vaccine program reset: navigating safety, acceptance and uptake 31/03/21: COVID-19 and 2021 influenza vaccines – the how, what, why and when 17/3/2021: COVID-19 vaccine safety in focus 19/2/2021: Out of the starting blocks: COVID-19 vaccination program in Australia - Part 2 12/02/2021 - Out of the starting blocks: COVID-19 vaccination program in Australia - Part 1 23/11/2020 - SARS-CoV-2 vaccine development: is a finish line in sight? 22/09/2020: Learning together – Transmission of SARS-CoV-2 in NSW educational settings 16/6/2020 - National Immunisation Program changes: what you need to know 17/03/2020 - 2020 influenza program update 18/2/2020 - Measles a local, regional and global perspective 10/12/19 - Working together to improve Aboriginal and Torres Strait Islander immunisation 22/10/19 - Addressing parents’ immunisation communication and information needs and SKAI eLearning module & provider website launch 23/7/19 - HPV vaccination impact: successes and opportunities 4/6/19- Deadly diseases: a history and the current battle against measles 1/5/19 - Protecting our most vulnerable children from influenza: we can do better 20/3/19 - All you need to know about Flu in 2019 plus great new tool to support vaccination in pregnancy 18/2/2019 - Conversations with vaccine-hesitant parents: how the new SKAI website can help 21/11/18 - Australian Immunisation Register & Handbook Update 3/10/18 - Immunisation through an equity lens: New Zealand and global 19/09/18 Vaccine safety and adverse events following immunisation: a practical approach 11/07/18 - National Immunisation Program schedule changes - Your questions answered 31/05/18 Maternal vaccination: The knowns and unknowns 23/4/18 - Active surveillance for immunisation programs 12/03/18 - Influenza prevention and control: We can do better 22/11/17 - Tailoring Immunization Programmes (TIP) 27/09/17 - Addressing vaccine hesitancy and refusal 23/08/17 Varicella Zoster Virus Vaccines 26/07/17 - Tuberculosis & the Bacille Calmette-Guérin (BCG) vaccine 24/05/17 Maternal Immunisation against Pertussis 22/03/17 - A One Health Approach to the Problem of Q Fever 22/2/17 - Pneumococcal vaccines for elderly adults Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS webinar series Main navigation Australian Immunisation Handbook Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources NCIRS webinar series 24/09/2026 – COVID-19 vaccination in 2026 – preparing for the transition to the National Immunisation Program 24/06/2026 – Pneumococcal vaccination for adults: expanding disease protection 23/04/2026 – RSV vaccines and prevention programs: evidence, safety and impact 05/03/2026 – Influenza vaccination in 2026: a new era of protection 05/11/2025 – Protecting adolescents through immunisation: insights, drivers and opportunities for action 25/09/2025 – What’s new in pneumococcal vaccination for infants, children and adolescents 25/06/2025 – Navigating vaccination for immunocompromised patients: New Handbook guidance 27/03/2025 – Triple protection: Vaccines for influenza, COVID-19 and RSV in 2025 06/02/2025 – Australian RSV immunisation update – new funded programs for infant protection 10/10/2024 – Falling childhood vaccination rates: current context and future strategies 08/08/2024 – Rabies, travel vaccines and global trends in vaccine-preventable diseases 27/03/2024 – Influenza and COVID-19 vaccination update 07/03/2024 – RSV vaccines for the protection of older adults 27/02/2024 – New RSV vaccine and antibody to prevent disease in infants 07/11/2023 - New shingles vaccine on Australia's NIP 22/09/23 – Vaccination for people with disability 05/05/2023: HPV in 2023 – latest vaccine recommendations and research 16/03/2023: COVID-19 and influenza vaccination update 2023 8/11/2022: Mpox (formerly monkeypox) vaccines 01/09/2022: Emerging vaccine preventable diseases and vaccination for travel 12/05/2022: Preventing shingles (herpes zoster) and its complications using zoster vaccines - and a quick update on COVID-19 vaccines 05/04/2022: Managing seasonal respiratory viruses: Flu and SARS-CoV-2 Winter 2022 03/03/2022: Living with COVID-19: Getting back to immunisation business as usual 8/12/2021: COVID-19 in children and adolescents: vaccines, transmission at school and disease outcomes 13/10/2021: Weighing up the benefits and risks of COVID-19 vaccination: a focus on safety - REGISTER NOW 26/08/21 - What’s next for Australia’s COVID-19 vaccine program? 24/06/2021 - Supporting COVID-19 vaccine access in the Indo-Pacific 30/04/2021: Australia’s COVID-19 vaccine program reset: navigating safety, acceptance and uptake 31/03/21: COVID-19 and 2021 influenza vaccines – the how, what, why and when 17/3/2021: COVID-19 vaccine safety in focus 19/2/2021: Out of the starting blocks: COVID-19 vaccination program in Australia - Part 2 12/02/2021 - Out of the starting blocks: COVID-19 vaccination program in Australia - Part 1 23/11/2020 - SARS-CoV-2 vaccine development: is a finish line in sight? 22/09/2020: Learning together – Transmission of SARS-CoV-2 in NSW educational settings 16/6/2020 - National Immunisation Program changes: what you need to know 17/03/2020 - 2020 influenza program update 18/2/2020 - Measles a local, regional and global perspective 10/12/19 - Working together to improve Aboriginal and Torres Strait Islander immunisation 22/10/19 - Addressing parents’ immunisation communication and information needs and SKAI eLearning module & provider website launch 23/7/19 - HPV vaccination impact: successes and opportunities 4/6/19- Deadly diseases: a history and the current battle against measles 1/5/19 - Protecting our most vulnerable children from influenza: we can do better 20/3/19 - All you need to know about Flu in 2019 plus great new tool to support vaccination in pregnancy 18/2/2019 - Conversations with vaccine-hesitant parents: how the new SKAI website can help 21/11/18 - Australian Immunisation Register & Handbook Update 3/10/18 - Immunisation through an equity lens: New Zealand and global 19/09/18 Vaccine safety and adverse events following immunisation: a practical approach 11/07/18 - National Immunisation Program schedule changes - Your questions answered 31/05/18 Maternal vaccination: The knowns and unknowns 23/4/18 - Active surveillance for immunisation programs 12/03/18 - Influenza prevention and control: We can do better 22/11/17 - Tailoring Immunization Programmes (TIP) 27/09/17 - Addressing vaccine hesitancy and refusal 23/08/17 Varicella Zoster Virus Vaccines 26/07/17 - Tuberculosis & the Bacille Calmette-Guérin (BCG) vaccine 24/05/17 Maternal Immunisation against Pertussis 22/03/17 - A One Health Approach to the Problem of Q Fever 22/2/17 - Pneumococcal vaccines for elderly adults Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety From 1 October 2026, COVID-19 vaccines will transition to the National Immunisation Program (NIP), marking a significant change in how COVID-19 vaccination is funded and managed in Australia. The move reflects current evidence and changed epidemiology of COVID-19 in Australia and prioritises maintaining protection against severe COVID-19 in those at highest risk.The webinar covered:the burden of COVID-19 disease in Australiathe evidence on COVID-19 vaccine effectiveness and safetyupdated COVID-19 vaccination recommendations, the reasons for these changes and eligibility for a funded dosethe implications of the transition to the NIP for providers and patientspractical approaches to discussing vaccination recommendations with patientsvaccine ordering, distribution and delivery under NIP arrangements.The session will concluded with a live Q&A panel. Presenters Professor Kristine Macartney, Director, NCIRS Kristine Macartney is a paediatrician and infectious disease specialist. She is a medical graduate of UNSW Sydney and has over 20 years of experience in vaccinology.Kristine is a Staff Specialist in Infectious Diseases and Microbiology at the Children’s Hospital at Westmead, has a conjoint academic appointment as Professor in the Discipline of Child and Adolescent Health at the University of Sydney, and is the Senior Editor of the Australian Immunisation Handbook. She has experience working in the US at the Children’s Hospital of Philadelphia, where she was a founding member of the US Vaccine Education Center. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates. She is interested in all aspects of vaccine preventable disease research, particularly policy development, vaccine safety and prevention of viral diseases. Dr Tran Nguyen, Senior Medical Officer, NCIRS Tran Nguyen is a Senior Medical Officer in the Research to Inform Policy team at NCIRS. She also works as a general paediatrician and paediatric infectious diseases physician at Bankstown Hospital and in private practice. Tran is an Adjunct Lecturer at the Sydney Children’s Hospital, Faculty of Medicine and Health, UNSW Sydney, and has extensive experience working in the Specialist Immunisation Clinic. Tran has been involved in many clinical trials, including vaccine trials. She is a member of the Australasian Society of Infectious Diseases. Professor Katie Flanagan, Senior Staff Specialist in Infectious Diseases, Westmead Hospital Katie Flanagan is a clinician scientist who has worked on global health issues for more than 25 years. She has led numerous vaccine immunology trials throughout the world, including trials of novel malaria and HIV vaccines in African infants and trials of the immunological effects of commonly used vaccines in young and older people. Katie holds academic positions, including Clinical Professor at the University of Tasmania, Adjunct Professor, Sydney Infectious Diseases Institute, University of Sydney and adjunct Professor at RMIT University in Melbourne. Ms Kelly Trudgen, National Indigenous Immunisation Lead, NCIRS Kelly Trudgen is a proud Gumbaynngirr woman, currently living on Yuggera and Tuurbal Country. She has over 30 years’ experience in nursing – in both military and civilian nursing contexts – with particular expertise in advanced clinical practice, clinical leadership and health management.Kelly is committed to adopting innovative measures to ensure optimal health outcomes for Aboriginal and Torres Strait Islander Peoples, and to building a strong Aboriginal and Torres Strait Islander workforce. Her lived experience of Aboriginal and Torres Strait Islander healthcare is informed by her work across both the public- and community-controlled sectors. Kelly’s skills and knowledge are enhanced by postgraduate qualifications in Emergency Nursing, Public Health, and Emergency and Disaster Management. Ms Karen Bellamy, Nurse Practitioner, Monash Health Kaz Bellamy is an Infectious Diseases and Immunisation Nurse Practitioner with specialist expertise in high-risk, antenataland travel immunisation. Kaz has played a key role in developing adult and paediatric immunisation sedation pathways at Monash Health. She has extensive experience in vaccine safety and vaccine preventable disease research across both adult and paediatric populations, bringing strong clinical and research leadership to immunisation practice. Kaz is a current member of the Australian Technical Advisory Group on Immunisation (ATAGI). Mr Peter Guthrey, Senior Pharmacist – Strategic Policy, Pharmaceutical Society of Australia Peter Guthrey holds the position of Senior Pharmacist, Strategic Policy at the Pharmaceutical Society of Australia (PSA). Peter supports policy development, advocacy activities, regulatory submissions and practice advice. He has driven key PSA policy work, including development of the Pharmacists in 2023 and Pharmacists in 2030 reports, and PSA’s medicine safety agenda, including the flagship Medicine Safety series.Peter has over 18 years’ experience in pharmacy policy, regulation, advocacy, quality management and community pharmacy practice. He maintains practice as a community pharmacist, working after-hours at a Melbourne pharmacy. 1203 views